Reneo Pharmaceuticals, Inc. (RPHM)
NASDAQ: RPHM · IEX Real-Time Price · USD
5.58
+0.16 (2.95%)
Mar 29, 2023, 4:30 PM EDT - Market closed
RPHM Market Cap
RPHM has a market cap or net worth of $136.88 million as of March 30, 2023. Its market cap has increased by 58.09% in one year.
Market Cap
136.88M
Enterprise Value
37.17M
1-Year Change
58.09%
Ranking
Category
Stock Price
$5.58
Market Cap Chart
Since the IPO on April 9, 2021, Reneo Pharmaceuticals, Inc.'s market cap has decreased from $363.16M to $136.88M, a decrease of -62.31%. That is a compound annual growth rate of -39.06%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 29, 2023 | 136.88M | 3.09% |
Mar 28, 2023 | 132.77M | -8.14% |
Mar 27, 2023 | 144.53M | -2.32% |
Mar 24, 2023 | 147.96M | 8.44% |
Mar 23, 2023 | 136.44M | -13.24% |
Mar 22, 2023 | 157.27M | 3.88% |
Mar 21, 2023 | 151.39M | 5.46% |
Mar 20, 2023 | 143.55M | 2.63% |
Mar 17, 2023 | 139.87M | 25.22% |
Mar 16, 2023 | 111.70M | 4.83% |
Mar 15, 2023 | 106.56M | -2.25% |
Mar 14, 2023 | 109.01M | 2.77% |
Mar 13, 2023 | 106.07M | 1.88% |
Mar 10, 2023 | 104.11M | -13.18% |
Mar 9, 2023 | 119.91M | -4.02% |
Mar 8, 2023 | 124.93M | 17.24% |
Mar 7, 2023 | 106.56M | 1.16% |
Mar 6, 2023 | 105.33M | 2.38% |
Mar 3, 2023 | 102.88M | -2.33% |
Mar 2, 2023 | 105.33M | 30.70% |
Mar 1, 2023 | 80.59M | 8.22% |
Feb 28, 2023 | 74.47M | -3.80% |
Feb 27, 2023 | 77.41M | 7.12% |
Feb 24, 2023 | 72.26M | -3.91% |
Feb 23, 2023 | 75.20M | 2.68% |
View and export this data all the way back to 2021.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Cardiff Oncology, Inc. | 65.23M |
Aligos Therapeutics, Inc. | 49.81M |
Daxor Corporation | 48.19M |
Sensei Biotherapeutics, Inc. | 40.55M |
Novan, Inc. | 32.65M |
Vaccinex, Inc. | 20.45M |
RedHill Biopharma Ltd. | 11.01M |